oral semaglutide dissolving tablets Wegovy Pill: First GLP-1 for Weight Loss (2025) Oral Semaglutide Tablets WL.png

and skip the alcohol, caffeine, and late-night snacks

(Ozempic and Wegovy are both the same moleculesemaglutideand are made and sold by Novo Nordisk.) In 2023, a clinical trial called Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) showed that Wegovy can significantly reduce the risk of major heart eventsthis time in people with extra weight and a cardiovascular condition who dont have diabetes

People eat significantly less

It typically peaks during the first 1 to 2 weeks after each dose increase and subsides as the body adjusts

The average weight loss achieved in the Semaglutide FDA study for weight loss was almost 15% of the initial body weight but it is not unusual to see a patient lose 20% of their body weight over the course of the treatment